Reducing Side Effects of Chloroquine with <i>Medicinal Synthetic Aluminum-Magnesium Silicate</i>® [Msams: Al<sub>4</sub>(SiO<sub>4</sub>)<sub>3</sub> + 3Mg<sub>2</sub>SiO<sub>4</sub> →2Al<sub>2</sub>Mg<sub>3</sub>(SiO<sub>4</sub>)<sub>3</sub>] before Assessing Its Anti-Covid-19 Efficacy — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Reducing Side Effects of Chloroquine with <i>Medicinal Synthetic Aluminum-Magnesium Silicate</i>® [Msams: Al<sub>4</sub>(SiO<sub>4</sub>)<sub>3</sub> + 3Mg<sub>2</sub>SiO<sub>4</sub> →2Al<sub>2</sub>Mg<sub>3</sub>(SiO<sub>4</sub>)<sub>3</sub>] before Assessing Its Anti-Covid-19 Efficacy
College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
,
College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
,
College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
,
College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
,
College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
,
College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
,
College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
,
College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
,
Directorate of Information Computer Technology, Michael Okpara University of Agriculture, Umudike, Nigeria
1 College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
2 College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
3 College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
4 College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
5 College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
6 College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
7 College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
8 College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria
9 Directorate of Information Computer Technology, Michael Okpara University of Agriculture, Umudike, Nigeria
To reduce Chloroquine’s (CQ) side effects, so that increasing its duration for anti- Covid -19 trials could be safe, the drug was potentiated by stabilizing it with Medicinal synthetic Aluminum-magnesium silicate (MSAMS). CQ-treatment for five Plasmodium berghie -infected mice-groups were: 7 mg/kg (normal dose); 7 mg/kg (CQ-MSAMS); 7 mg/kg (CQ-MSAMS + B-vitamins), 5.25 mg/kg (CQ-MSAMS + B-vitamins) and the control. Means of parasitaemia, 42.00 ± 15.74 of the normal-dose group, 37.22 ± 11.88 of the 7 mg/kg (CQ-MSAMS) group and 33.57 ± 12.62 of the 7 mg/kg (CQ-MSAMS + B-vitamins) group showed no significant (P ≥ 0.05) reduction from 52.50 ± 11.99 of the control, but the 5.25 mg/kg (CQ-MSAMS + B-vitamins) dose, cleared (P ≤ 0.01) the parasiteamia (00.00 ± 00.00), showing that MSAMS-potentiated Chloroquine, has best efficacy at 75% of the recommended dose. Fever and anemia were absent at that 5.25 mg/kg, suggesting that lower doses of CQ have reduced side effects.
KeywordsAntiviral Treatment with ChloroquineLower DosesReduction of Side EffectsMSAMS
Singh, B., Kim-Sung, L. and Matusop, A. (2004) A Large Focus of Naturally Acquired Plasmodium Knowlesi Infection in Human Beings. The Lancet, 363, 1017-1024. https://doi.org/10.1016/S0140-6736(04)15836-4
Mueller, I., Zimmerman, P.A. and Reeder, J.C. (2007) Plasmodium Malria and Plasmodium ovale—“Bashful Malaria Parasite”. Trends in Parasitology, 23, 278-283. https://doi.org/10.1016/j.pt.2007.04.009
Vincke, I.H. and Lips, M. (1948) Plasmodium berghei. Annales de la Societe Belge de Medecine Tropical, 28, 97-104.
Escalante, A. and Ayala, F. (1994) Phylogeny of the Malarial Genus, Plasmodium, Derived from RNA Gene Sequences. Proceedings of the National Academy of Sciences USA, 91, 11373-11377. https://doi.org/10.1073/pnas.91.24.11373
Collins, W.E. and Aikawa, M. (1977) Plasmodia of Non-Human Primates. In: Kreier, J.P., Ed., Parasitic Protozoa, Academic Press, New York, 467-492.
Chen, Q., Schlichtherle, M. and Wahlgren, M. (2000) Molecular Aspects of Severe Malaria. Clinical Microbiology Review, 13, 439-450. https://doi.org/10.1128/CMR.13.3.439
Snow, R.W., Querra, C.A., Noor, A.M., Myint, H.Y. and Hay, S.I. (2005) The Global Distribution of Clinical Episodes of Plasmodium falciparum Malaria. Nature, 434, 214-217. https://doi.org/10.1038/nature03342
Wards, B.P. and Fidock, D. (2004) Understanding How the Malaria Parasite Resists Chloroquine. Molecular Cell, 15, 867-877. https://doi.org/10.1016/j.molcel.2004.09.012
Wellems, T.E. (2002) Plasmodium, Chloroquine Resistance and the Search for a Replacement Antimalarial Drug. Science, 298, 124-126. https://doi.org/10.1126/science.1078167
Technical Literature-Veegum Inc. (1992) The Versatile Ingredient for Pharmaceutical Formulations. http://www.rtvanderbilt.com
Elendu-Eleke, N.P. (2014) Effect of Aluminum-Magnesium Silicate on Antiplasmodial Activity of Chloroquine Phosphate. M.Sc., University of Nigeria, Nsukka.
Brent, W., Gigi, H.R., Khalid, H.I. and John, C.R. (2001) What Do We Really Know about Antibiotic Pharmacodynamics? Pharmacotherapy, 21, 3028-3088.
Ezeibe, M.C.O., Ofafor, U.C., Okoroafor, O.N., Eze, J.I., Ngene, A.A., Animoke, P.C. and Mbuko, I.J. (2011) Effect of Aluminium-Magnesium Silicate on Anticoccidial Activity of Sulphadimidin. Tropical Veterinary, 29, 41-44.
Ezeibe, M.C.O., Chima, U.M., Ngene, A.A., Okoroafor, O.N., Kalu, I.I. and Esen, M.E. (2012) Effective Treatment of Resistant Escherichia coli Infection, with Sulphadimidine Stabilized in a Synthetic Aluminum-Magnesium Silicate. Health, 4, 1295-1298. https://doi.org/10.4236/health.2012.412190
Ezeibe, M.C.O., Dire, C.D., Anosa, G.N., Chikelu, O.N., Okoroafor, O.N., Okorie, O.K., Ngene, A.A., Idika, I.K., Ogunniran, T.M. and Ezeala, I.E. (2012) Efficacy of Piparazine Citrate, Stabilized with Aluminum-Magnesium Silicate, against Helignosomoides bakeri. Health, 4, 890-892. https://doi.org/10.4236/health.2012.410135
Ezeibe, M.C.O., Anosa, G.N., Okorie, O.K., Elendu-Eleke, N.P., Okoroafor, O.N., Ngene, A.A. and Chikelu, O.N. (2012) Antibiotic Activity of Ampicillin trihydrate Formulated in Aluminum-Magnesium Silicate, against Salmonella gallinarum. Health, 4, 675-678. https://doi.org/10.4236/health.2012.49106
Ezeibe, M.C.O., Ezeobele, O.K, Esen, M.E., Ngene, A.A., Mbuko, I.J., Chukwudi, I.C., Omoja, V.U. and Ezeh, I.O. (2013) Synergy in Antibacterial Activities of Ampicillin trihydrate, Stabilized with a Synthetic Aluminum-Magnesium Silicate and Immune-Stimulants, on Resistant Escherichia coli Infection. Health, 5, 1548-1552. https://doi.org/10.4236/health.2013.510210
Ezeibe, M.C.O., Udom, A.E., Onyeachonam and Ogbonna, I.J. (2019) Restoring Efficacy to Cotrimoxazole against Resistant Salmonella pullorum with Medicinal Synthetic Aluminum-Magnesium Silicate: Al4(SiO4)3 + 3Mg2SiO4 → 2Al2Mg3(SiO4)3. Health, 11, 1162-1168.
Emerson, L.R., Martin, E.M., Rodger, K., Martin, D., Kyle, E., Vahey, M. and Wirth, D.F. (2001) Relationship between Chloroquine Toxicity and Acquisition in Saccharomyces cerevisae. Antimicrobial Agents and Chemotherapy, 46, 114-117. https://doi.org/10.1128/AAC.46.3.787-796.2002
Hempelmann, E. (2007) Hemozoin Biocrystallization in Plasmodium falciparum and the Antimalarial Activity of Crystallization Inhibitors. Parasitology Research, 100, 671-676. https://doi.org/10.1007/s00436-006-0313-x
Carter, R. and Diggs, C.I. (1977) Plasmodia of Rodents. In: Kreier, J.P., Ed., Parasitic Protozoa, Academic Press, New York, 359-465.
Ezeibe, M.C.O., Elendu-Eleke, N.P., Okoroafor, O.N. and Ngene, A.A. (2012) Adjuvant Effect of a Synthetic Aluminum-Magnesium Silicate on Chloroquine Phosphate against Plasmodium berghei. Health, 4, 448-451. https://doi.org/10.4236/health.2012.48071
Ezeibe, M.C.O. (2017) Ismercquine® Aluminum-Magnesium Silicate-Chloroquine Formulation for Treatment of Malaria. Federal Republic of Nigeria Patents and Designs Ref. No: NG/P/2017/2423.
Ezeibe, M.C.O. (2017) Antivirt®-Broad Spectrum Antiviral Medicine and Antiretroviral Medicine. Federal Republic of Nigeria Patents and Designs Ref No: NG/P/2017/2418.